MIAMI, Nov. 24, 2015—Global Stem Cells Group announced the opening two new stem cell clinics in Tacna and Lima, Peru. The new clinics are part of GSCG’s expansion efforts in Latin America.
Both clinics will be headed by Aldo Parodi, M.D., owner of Clinic La Femme in Tacna, and specialist in regenerative medicine and stem cell therapy. Parodi, a cosmetic surgeon, is a GSCG faculty member.
The Tacna and Lima clinics will focus on offering the most advanced techniques and protocols in cosmetic stem cell medicine to patients from around the world.
Global Stem Cells Group is expanding its clinical presence throughout Latin America and worldwide by partnering with qualified physicians experienced in stem cell therapies to open new clinics. The new Tacna and Lima clinics are certified for the medical tourism market.
GSCG is committed to providing the highest standards in service and technology, expert and compassionate care, and a philosophy of exceeding the expectations of their international patients.
About the Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.
With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Groups corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCGs six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/